Professors from Stanford University developed non-invasive, wireless blood pressure monitoring. They needed brand development experts to raise capital.

Where all treatment decisions begin.


PyrAmes a spinout from Stanford University, is focused on transforming the delivery of health care through advanced sensor measurement. The Company is developing a proprietary platform to provide continuous blood pressure monitoring that is accurate, wireless and non-invasive. It is intended for patients of all ages, from newborns to seniors.

PyrAmes was getting ready to announce thier Series A Round but needed to hit the right tone in a market with competing technologies.


Partner Since

Life Sciences

Bay Area, CA

Hello, world.

Our relationship is deep, having worked with the executive team and board members on previous ventures.  The PyrAmes team was in a position many early stage medtech ventures find themselves: encouraging trial data, eager investors and endless market applications.

They needed to make the right impact from Day 1.

Together we set out on key initiatives…

Key Initiatives Included:

Partner with executive team in developing value proposition.


Key Initiatives Included:

Develop commercialization framework.


Key Initiatives Included:

Enhance and streamline communication platform.


Key Initiatives Included:

Develop digital footprint to inform investor, academic and commercial audiences.


“Since our inception, our focus has been on clinical development.

Howbridge has been a wonderful partner that balances our immediate needs with a flow to the future that examines our business, commercialization as well subsequent funding rounds.”

– Xina Quan, PhD, Co-founder & CEO, PyrAmes

A structure to capitalize & commercialize.

Through our strategic initiatives, PyrAmes achieved key milestones, including:

Enhanced value proposition & communication strategies.

Strategic plan for go-to-market & fundraising.

Greater engagement with investor group & early adopters.